Bringing new treatments to patients faster and more efficiently. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

178 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery Anuva is creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery. Anuva is a translational research company that is creating the most diverse Genomic Bio/Data Bank of Asian Populations, which is being utilized for research & development within the pharma industry. Our cohorts and biorepository allow for follow-on clinical and translational studies, which greatly empower drug development opportunities. IndiaCHIP, Genomics, Genomics - Emerging markets, Genomics - R&D, Genomics Data Platform, Genomics - India, bioinformatics, and …

65 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology

Flindr develops first-in-class precision oncology therapies identified through the Immunogram Drug Discovery Engine Flindr Therapeutics, based in Oss in the Netherlands, is a private pre-clinical biotech company developing next-generation precision oncology treatments. The Company, previously called Immagene, was spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute in 2020, by founders Prof Daniel Peeper, Prof Christian Blank and Dr Maarten Ligtenberg. Flindr is actively building a pipeline of highly promising, first-in-class precision oncology therapies identified through the ImmunoGram Drug Discovery Engine. It is backed by V-Bio Ventures, Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future …

41 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Unravelling complex biology with optogenetics, chemistry and computation for small molecule discovery. Our platform is built around a proprietary synthetic biology toolkit, featuring advanced optogenetic tools that enable precise temporal and spatial control of complex pathways and difficult-to-drug targets. Powered by vast proprietary datasets and cutting-edge AI models, our platform accelerates drug discovery and facilitates the generation of novel chemical matter, unlocking solutions for even the most challenging biological systems. biotechnology, aging, drug discovery, machine learning, synthetic biology, optogenetics, artificial intelligence, small molecule, rejuvenation, molecular biology, and novel therapeutics

203 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

Complete genes for complete cures Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them. Biotechnology, DNA therapeutics, Gene therapy, CRISPR, and Biological engineering

113 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A precision oncology company integrating multiomics to develop innovative diagnostic and therapeutic products. Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.

31 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer

295 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos. Cancer / Oncology, Drug Discovery and Development, and Biotechnology

160 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advancing cancer care through microbiome profiling 🦠 Discover your microbiome: www.mybioma.com Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has …

52 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology A.I. A.I. - Machine Learning

Therapeutics for the Disease of Aging Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases Oncology, Aging, Dark Genome, ALS, Diabetes, and Longevity

198 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer

167 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, …

60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalised estimates of risk for all the common diseases and cancers, well ahead of …

81 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

We are a genetics company transforming the way pharmaceutical companies develop drugs to include non-european data. Biomedical research driving transformation in healthcare through genomics. Complete our 3-min survey: https://forms.gle/MFApRSWVno63c1Fx5 Biomedical, Biodiversity, Genome Research, Healthcare, Environment, Conservation, Caribbean, and Biotech

93 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc

154 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality.

113 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology Data Analytics

New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes

346 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases

338 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Driving Precision Medicine Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated …

45 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Data Analytics

Preventing deaths from cancer metastases Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.

294 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

574 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

CircaGene platform for personal genetic tests World's first Patented Incognito DNA Encryption with actionable result The mission of CircaGene is to provide world-class BioInformatics Services to protect and improve Public Health both at population and individual levels. Bioinformatics, Sequencing, Genomic, Genetic Data Privacy, Actionable Genomics, Genetic Coach, Optimised Lifestyle, Science in your side, DNApower, and Genetic Heroe

46 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Data Analytics

Ultimate predictability Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. …

60 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

196 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

True precision medicine through single-cell science. True precision medicine through single-cell science. Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles. The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality. If you want to partner with, reach out …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare

245 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology A.I.

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker …

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis

110 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating the world's transition to precision medicine. At Sano, our mission is to accelerate the world's transition to precision medicine. Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients. Genetics, Big Data, and Research

39 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection

89 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

We turn blood stem cells into living drug factories At Immitra Bio, we are pioneering a next-generation gene therapy platform, harnessing Hematopoietic Stem Cells and their downstream cell lineages, such as red blood cells as living, in-vivo biotherapeutic protein factories. The CRISPR-Cas-based cell and gene therapy platform we are developing is versatile and promises to be easily reprogrammable.

221 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency.

260 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions …

34 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating the Development of New Medicines with Targeted Proteomics Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development. Proteomics, Biomarker Discovery, Translational Biomarkers, Mass Spectrometry, Targeted Proteomics, Discovery Proteomics, Biomarkers, Precision Medicine, Proteomic Analysis, Proteome Profiling , Quantitative Proteomics, Liquid Chromatography Mass-Spectrometry (LC-MS), Post-Translational Modifications (PTMs), Quantitative Biomarkers, Clinical Proteomics, Immuno-Precipitation Mass Spectrometry (IP-MS), Proteins, LC-MS Proteomics, Proteomics Services, and Protein Identification

165 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

The Genome Optimised Data Store: Enabling healthcare transformation using big data technology Zetta Genomics unleashes the power of precision medicine – shaping the future of genomic data to transform the health of millions of people around the world. bioinformatics, genomics, genomic medicine, precision medicine, and biomedical research

112 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Data Analytics

Expertise that matters Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines. Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions. Our vision is to improve human health …

140 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

299 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Precision in Cancer Diagnostics oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. Diagnostik, Epigenetik, Medizin, Assay Development, Diagnostics, DNA-Methylation, Medicine, and LifeScience Developments

123 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

More Omics into Clinics Pioneering the integration of DNA & RNA sequencing data with AI for rare disease diagnostics Follow us on Twitter @PhiTech_Bioinfo Bioinformatics, Genomics, Transcriptomics, Epigenomics, AI, and Rare Diseases

135 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics

436 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy

59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies

540 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens.

505 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

605 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules

550 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

BiogeniQ helps people optimize their nutrition and medication based on their genetic composition. We allow everyone to access important portions of their DNA, while providing a useful tool for healthcare professionals. We put emphasis on solid, peer-reviewed research and integration of our genetic reports into future healthcare. Médecine Personnalisée, Dépistage Génétique, Nutrigénomique, Pharmacogénétique, Génotypage, and Génomique

23 similar entities Type: Startup Activities: biotech deeptech

The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics

383 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Unlock genomic insights Emedgene is on a mission to unlock genomic insights for the world’s health organizations by providing data-driven AI solutions for genomic diagnostics and discovery at scale. We work with leading healthcare and life sciences organizations to enable precision medicine programs, enable high throughput diagnostics and accelerate the pace of research. Genomics, Human Genetics, Big Data, and Algorithms

155 similar entities Type: Startup Activities: biotech deeptech it services Technologies: A.I. A.I. - Machine Learning

Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

504 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory

376 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Discovering from Green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with high -value added properties (of interest to the consumer, farmers and the agri -food industry) and more stress resistant, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced genomics, proteomic, metabolomic, bioinformatics, microscopy, quantification of plant hormones, DNA sequencing and gene expression analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomic, Proteomic, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology

251 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Master Genomic Analysis: User-Friendly, Adaptable & Comprehensive solution for Professionals Intelliseq provides state of the art solutions for next generation sequencing. A team of passionate and skilled bioinformaticians, geneticists and molecular biologists approaches next generation DNA sequencing challenges with creativity and flexibility. bioinformatics, next generation sequencing, biotechnology, diagnostics, and genetics

45 similar entities Type: Startup Activities: deeptech Technologies: Data Analytics

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

232 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

BioProcess InternationalTM is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process. BPI is a business unit of Informa Connect https://informaconnect.com marketing, Biopharmaceutical, biotechnology, print, electronic, online, advertising programs, bioprocessing, vaccines, monoclonal antibodies, protein therapeutics, cell therapies, gene therapy, cell therapy, and biomanufacturing

181 similar entities Type: SMB Activities: biotech deeptech martech Technologies: Synthetic Biology

Leader in Clinical Diagnostic Testing & Biopharma Services. ***INC. 2024 Best Workplaces*** A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. INC. 2024 Best Workplaces #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #lifesciences #diagnostics Molecular Diagnostics, Predictive, Prognostic and Mutation Tests, Companion Diagnostics, Mass Spectrometry Analysis of Biological Samples, oncology, lung cancer, lung disease, cancer diagnostics, biomarkers, liquid biopsy, ddPCR, Non-Small Cell Lung Cancer, Lung Nodules, Nodule Management, Proteomics, Artificial Intelligence, Genomic Testing, Clinical Trials, Biopharma Services, genomics, and …

94 similar entities Type: SMB Activities: deeptech biotech Technologies: A.I. Synthetic Biology

A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and …

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is …

41 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

The RNA Platform - by analyzing RNA we can detect disease, monitor health and design the Next Generation Cures Today only 1 out if 4 cancer drugs prolongs life because we treat all the patients the same way. Genomic Expression’s OneRNATM test can save lives and make healthcare delivery more effective by sequencing RNA and linking RNA’s to approved therapies and clinical trials. Genomics, information, personalized medicine, personalized diagnostics, Sequencing, prognostics, bioinformatics, sample preparation, Next Generation Sequencing, Biobank, Access to biological samples, target filtering, RNA-seq, RNA sequencing, and RNASeq of FFPE samples

102 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners …

186 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Founded in 1997, Genedata delivers enterprise solutions to enable Biopharma R&D globally to discover, develop, and manufacture innovative biotherapeutics faster and more efficiently. Genedata combines computational, scientific, and technical expertise with extensive biopharma R&D domain knowledge to deliver user-friendly solutions that are scalable, open, and aligned with industry processes. Today, most of the leading pharmaceutical, biotechnology, and agrichemical companies, as well as innovative life science research institutions rely on Genedata. Genedata is proud to be part of Danaher. Danaher’s science and technology leadership puts Genedata’s solutions at the forefront of the industry, so they can reach more people. Being part …

9 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders. Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies. gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines

288 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy

543 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk

328 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Expediting the discovery and translation of precision medicine. web-based no-code auto machine learning platform that's tuned for analyzing biomedical data to find disease markers, therapies and drug targets machine learning, signature building, biomarker discovery, and precision medicine

86 similar entities Type: SMB Activities: biotech Technologies: A.I. A.I. - Machine Learning

Precision Health and Genomics AI Platform LifeNome is a precision (biology-personalized) health platform powered by Genomics AI (c). We leverage systems-biology, multi-omics, and proprietary artificial intelligence to personalize health and wellbeing services and products of healthcare, insurance, pharmaceutical, nutrition, and fitness organizations worldwide. Our focus areas include precision preventive health (disease screening and intervention design), precision maternal and family health, and precision nutrition, and wellbeing. Awards and Recognitions: - LG Select 10 ($2 Million) - PEPSICO $100K Top Prize Food Tech Accelerator - Best Enterprise Precision Health and Wellness Platform (Biotech Awards, 2021) - Top Personalized Health Startup (Lux Research, …

60 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica

70 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav, Huntington's disease, gene therapy, ALS, epilepsy, and Fabry disease

160 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech

354 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The essential biodata life science partner for rare and neurodegenerative diseases CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization. Biochemical diagnostic test, Genetic diagnostic test, Rare diseases, Congenital diseases, Oncogenetics, Clinical and medical interpretation of genetic data, Next Generation …

155 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology